Several leading cancer research centres have partnered to launch Juno Therapeutics, a cancer immunotherapy startup, which has received one of the largest series A rounds in history.
Seattle-based Fred Hutchinson Cancer Research Centre and the Seattle Children’s Research Institute partnered on the New York City-based Memorial Sloan-Kettering Cancer Centre (MSKCC) to launch the venture.
Investors include venture firm and former spin-out of the University of Chicago ARCH Venture Partners (Chicago remains a partner and investor) and the Alaska…
Juno brings big guns against cancer
Dec 5, 2013 •
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
More universities adopt investor-friendly IP spinout terms
More universities adopt investor-friendly IP spinout terms
Academic institutions are taking new approaches to transferring intellectual property rights of university research in a bid to help spinouts attract investors.
Events
GCV Institute: Landing the Value of Corporate Venturing
May 6 -
May 9, 2024
Online
May 9, 2024
Online
Events
Webinar: CVCs and the art of the follow-on
May 8, 2024
Online
Online
Events
GCV Institute: CVC Investment Programs
May 21 -
May 22, 2024
Online
May 22, 2024
Online
Events
GCV Symposium 2024
Jun 24 -
Jun 26, 2024
London (UK)
Jun 26, 2024
London (UK)
Events
Corporate Venture in Brasil 2024 – International Delegation to Brazil
Oct 28 -
Oct 30, 2024
São Paulo (Brazil)
Oct 30, 2024
São Paulo (Brazil)
Top News
test reg